About

About Cellgenemedix InC

Cellgenemedix InC is a startup made in 2020 with goals in serving medical science and distributing medical diagnostic and therapeutic products made in the Republic of Korea. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our team delivers a combination of innovative technologies, purchasing diagnostic and pharmaceutical services through our brands, including Cellgenemedix, Precision Bio, Diamedi Clinic, Hilly PMC Clinic and Good Gene InC.

Cellgene Medix is the main co-manufacturer and PanAsia/EU/American continent distributor of Cellgenmedix korea (Cellgenmedix Corp), with OEM(original equipment manufacturer) at Goodgene, Inc. (www.goodgenekorea.com), a biotech company based in Seoul, Korea. We have Korean ISO 9001:2015, ISO 14001, and ISO13485 certification for International Standards Organization (ISO), manufacture, and export. We manufacture and sell a number of molecular testing tools including COVID-19 PCR kits, especially GG Omicron/Delta Real-Time PCR kits, GG Quadplex RT-PCR, GoodAg COVID-19 Rapid antigen test, (Approved for use in Europe/Asia per CE/ISO and NOT AUTHORIZED OR CLEARED FOR USE IN THE USA) and DNA microarrays for the detection of infectious disease, cancer and guiding genomic information-based tailor-made treatment of infectious diseases and cancers. GoodGene owns Quality Management System Certificates for the ISO 9001, ISO 14001, and ISO 13485 for manufacturing of its products.

GoodGene owns Korean FDA-certification for cGMP manufacture and medical device sales. Based on the basic experimental data and years of experience, Cellgenemedix is currently launching a new multiplex PCR kit for detection of COVID-19 and its variants, as well as COVID-19 rapid antigen test kit. By using DNA and RNA of cancer cells from cancer patients, we developed and patented multiple test kits for the analysis of genetic variation and gene expressions which play a key role in cancer characteristics, drug sensitivity, and toxicity. We also have a hospital in South Korea (“One World Clinic”) specifically for tailor made therapy of incurable diseases such as advanced cancer or stem cell therapy where we treat patients without the restriction of American regulations such as the FDA(publications). We own these multidisciplinary facilities to improve patient care:

Contact: Cellgenemedix, Corp
243 Broadway #9188 Newark, NJ 07104
Tel+1-862-621-6960 Fax: +1 516 953 3453
www.cellgenmedix.com Korean

Manufacturer: Precision Bio Corp,

28 Digital-ro 30-gil #1113 Guro-gu, Seoul, Republic of Korea (08389)

Tel:+82-2-2088-0055
Fax: +82-2-3409-1330
contact@precisionbio.co

Contact us for product quote or collaborations.

For more information, please visit www.cellgenemedix.com/contact